Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

JOHN R FORINGER

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1053339564
CMS profile
47859
Location
HOUSTON, TX

General Payments · PY2019–2025

$214,823.24

  • Reported across 269 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$10,262.80

10 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $10,121.69 5
NOVARTIS PHARMACEUTICALS CORPORATION $119.86 4
ABBVIE INC. $21.25 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $116,933.35 163
PY2020 $28,230.82 51
PY2021 $122.79 2
PY2022 $17,915.34 18
PY2023 $22,060.18 14
PY2024 $19,297.96 11
PY2025 $10,262.80 10

Payment records · PY2025 (10)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.25 01/09/2025 Food and Beverage Undisputed 06/30/2026 1201870624 CMS
Novartis Pharmaceuticals Corporation $29.61 01/10/2025 Food and Beverage Undisputed 06/30/2026 1200368328 CMS
Novartis Pharmaceuticals Corporation $28.27 01/31/2025 Food and Beverage Undisputed 06/30/2026 1200368330 CMS
Novartis Pharmaceuticals Corporation $31.61 04/01/2025 Food and Beverage Undisputed 06/30/2026 1200368334 CMS
Novartis Pharmaceuticals Corporation $30.37 08/04/2025 Food and Beverage Undisputed 06/30/2026 1200368342 CMS
Otsuka America Pharmaceutical, Inc. $217.83 01/31/2025 Travel and Lodging Undisputed 06/30/2026 1227328247 CMS
Otsuka America Pharmaceutical, Inc. $121.86 04/01/2025 Food and Beverage Undisputed 06/30/2026 1227328249 CMS
Otsuka America Pharmaceutical, Inc. $3,796.00 05/02/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1227328251 CMS
Otsuka America Pharmaceutical, Inc. $2,190.00 05/30/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1227328253 CMS
Otsuka America Pharmaceutical, Inc. $3,796.00 07/02/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1227328255 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.